Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Biocytogen Pharmaceuticals Inks Antibody Deal with Neurocrine Biosciences

November 23, 2024
CompanyDeals

China Grand Pharmaceuticals Secures Distribution of Sirtex’s SIR-Spheres for Liver Cancer

October 31, 2024
CompanyDeals

Organon In-Licenses Eli Lilly’s Emgality and Rayvow for European Migraine Market

October 31, 2024
CompanyDrug

European Commission Expands Keytruda Indications for Advanced Cancer Treatments

December 10, 2024
CompanyDrug

HuidaGene Secures Rare Pediatric Disease Designation for CRISPR Therapy HG302 Targeting DMD

October 31, 2024
CompanyDeals

Blue Sail Medical Partners with Weifang Government on Healthcare Initiative

October 31, 2024
CompanyDrug

HighField Biopharmaceutical Doses First Patient in HFK1 Clinical Trial Targeting Solid Tumors

October 31, 2024
CompanyDeals

Kangtai Biological Partners with Bahrain Pharma Firm on Strategic Vaccine Production Agreement

November 26, 2024
CompanyDrug

EMA’s CHMP Gives Green Light to Sanofi’s Fexinidazole for Acute Sleeping Sickness Treatment

October 31, 2024
CompanyMedical Device

BGI Genomics Receives NMPA Approval for Innovative Colorectal Cancer Detection Kit

October 31, 2024
CompanyDrug

InventisBio’s KRAS G12C Inhibitor D-1553 Advances Toward Priority Review in China

October 31, 2024
Company

GSK’s CCO Calls China a Hotbed for Innovative Molecules and Licensing Deals

October 31, 2024
1 2 … 7 8 9 10 11 … 21 22
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up